NCT00502099View on ClinicalTrials.gov

Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4

PHASE4CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Hepatitis C
Interventions
DRUG

Pegylated interferon alpha 2a

Injections: 180 ug once per week

DRUG

Ribavirin

Tablets, 1000-1200 daily

DRUG

Pegylated interferon alpha 2 b plus ribavirin

Pegylated interferon alpha 2 b injections

All Listed Sponsors
collaborator

Ain Shams University

OTHER

lead

Amr Hafez

OTHER

NCT00502099 - Comparison of Pegasys Versus Peg-Intron for Treatment of Chronic Hepatitis C Genotype 4 | Biotech Hunter | Biotech Hunter